Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells

Molecular Nutrition and Food Research

Volumn 52, Issue 5, 2008, Pages 538-548

  Marel, Anna Kristina ^a,b   Lizard, Gérard ^a,b   Izard, Jean Claude ^c   Latruffe, Norbert ^a,b   Delmas, Dominique ^a,b  

^a Institut Médical de Génétique et d Immunologie   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Actichem   (France)

Author keywords

Cell cycle; Colon cancer; Polyphenols; Resveratrol; Vineatrol

Indexed keywords

VITACEAE; VITIS VINIFERA;

ANTINEOPLASTIC AGENT; DNA; RESVERATROL; STILBENE DERIVATIVE; XENOBIOTIC AGENT;

ARTICLE; CELL CYCLE; CELL DIVISION; CELL MEMBRANE PERMEABILITY; COLON TUMOR; DNA REPLICATION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; COLONIC NEOPLASMS; DNA REPLICATION; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; XENOBIOTICS;

EID: 48649105934     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700185     Document Type: Article

References (31)

1. Renaud, S. C., Gueguen, R., Schenker, J., d'Houtaud, A., Alcohol and mortality in middle-aged men from eastern France. Epidemiology 1998, 9, 184-188.
2. Delmas, D., Jannin, B., Latruffe, N., Resveratrol: Preventing properties against vascular alterations and ageing. Mol. Nutr. Food Res. 2005, 49, 377-395.
3. Delmas, D., Lancon, A., Colin, D., Jannin, B., Latruffe, N., Resveratrol as a chemopreventive agent: A promising molecule for fighting cancer. Curr. Drug Targets 2006, 7, 423-442.
4. Delmas, D., Passilly-Degrace, P., Jannin, B., Malki, M. C., Latruffe, N., Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int. J. Mol. Med. 2002, 10, 193-199.
5. Delmas, D., Rebe, C., Lacour, S., Filomenko, R. et al., Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J. Biol. Chem. 2003, 278, 41482-41490.
6. Schneider, Y., Vincent, F., Duranton, B., Badolo, L. et al., Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 2000, 158, 85-91.
7. Bernhard, D., Tinhofer, I., Tonko, M., Hubl, H. et al., Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 2000, 7, 834-842.
8. Fulda, S., Debatin, K. M., Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 2004, 23, 6702-6711.
9. Delmas, D., Rebe, C., Micheau, O., Athias, A. et al., Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 2004, 23, 8979-8986.
10. Billard, C., Izard, J. C., Roman, V., Kern, C., et al., Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Leuk. Lymphoma 2002, 43, 1991-2002.
11. Shang, X. Y., Wang, Y. H., Li, C., Zhang, C. Z. et al., Acetylated flavonol diglucosides from Meconopsis quintuplinervia. Phytochemistry 2006, 67, 511-515.
12. Li, Y., Chen, X., Satake, M., Oshima, Y., Ohizumi, Y., Acetylated flavonoid glycosides potentiating NGF action from Scoparia dulcis. J. Nat. Prod. 2004, 67, 725-727.
13. Okasaka, M., Takaishi, Y., Kogure, K., Fukuzawa, K. et al., New stilbene derivatives from Calligonum leucocladum. J. Nat. Prod. 2004, 67, 1044-1046.
14. Munkombwe, N. M., Acetylated phenolic glycosides from Harpagophytum procumbens. Phytochemistry 2003, 62, 1231-1234.
15. Riva, S., Monti, D., Luisetti, M., Danieli, B., Enzymatic modification of natural compounds with pharmacological properties. Ann. N. Y. Acad. Sci. 1998, 864, 70-80.
16. Kang, J. H., Park, Y. H., Choi, S. W., Yang, E. K., Lee, W. J., Resveratrol derivatives potently induce apoptosis in human promyelocytic leukemia cells. Exp. Mol. Med. 2003, 35, 467-474.
17. Kim, H. J., Chang, E. J., Bae, S. J., Shim, S. M. et al., Cytotoxic and antimutagenic stilbenes from seeds of Paeonia lactiflora. Arch. Pharm. Res. 2002, 25, 293-299.
18. Yamada, M., Hayashi, K., Ikeda, S., Tsutsui, K. et al., Inhibitory activity of plant stilbene oligomers against DNA topoisomerase II. Biol. Pharm. Bull. 2006, 29, 1504-1507.
19. Lambert, J. D., Sang, S., Hong, J., Kwon, S. J. et al., Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab. Dispos. 2006, 34, 2111-2116.
20. Bernhard, D., Schwaiger, W., Crazzolara, R., Tinhofer, I. et al., Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells. Cancer Lett. 2003, 195, 193-199.
21. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
22. Marshall, N. J., Goodwin, C. J., Holt, S. J., A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul. 1995, 5, 69-84.
23. Yeh, C. J., Hsi, B. L., Faulk, W. P., Propidium iodide as a nuclear marker in immunofluorescence. II. Use with cellular identification and viability studies. J. Immunol. Methods 1981, 43, 269-275.
24. Delmas, D., Jannin, B., Malki, M. C., Latruffe, N., Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol. Rep. 2000, 7, 847-852.
25. Cardile, V., Lombardo, L., Spatafora, C., Tringali, C., Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues. Bioorg. Chem. 2005, 33, 22-33.
26. Fragopoulou, E., Nomikos, T., Karantonis, H. C., Apostolakis, C. et al., Biological activity of acetylated phenolic compounds. J. Agric. Food Chem. 2007, 55, 80-89.
27. Hua, J., Sheng, Y., Bryngelsson, C., Kane, R., Pero, R. W., Comparison of antitumor activity of declopramide (3-chloroprocainamide) and N-acetyl-declopramide. Anticancer Res. 1999, 19, 285-290.
28. Pagliacci, M. C., Spinozzi, F., Migliorati, G., Fumi, G. et al., Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: A further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur. J. Cancer 1993, 29A, 1573-1577.
29. Ulrich, S., Loitsch, S. M., Rau, O., von Knethen, A. et al., Peroxisome proliferator-activated receptor {gamma} as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res. 2006, 66, 7348-7354.
30. Lu, J., Ho, C. H., Ghai, G., Chen, K. Y., Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces proapoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts. Carcinogenesis 2001, 22, 321-328.
31. Clement, M. V., Hirpara, J. L., Chawdhury, S. H., Pervaiz, S., Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998, 92, 996-1002.